Literature DB >> 10338395

Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition.

S B Rizoli1, A Kapus, J Parodo, O D Rotstein.   

Abstract

BACKGROUND: Neutrophil sequestration in the lungs plays an important role in the development of acute respiratory distress syndrome. We previously reported that hypertonic saline resuscitation attenuated lung injury after hemorrhagic shock and lipopolysaccharide (LPS) by abolishing neutrophil CD11b up-regulation. We investigated the mechanism underlying this effect.
METHODS: Human neutrophils were exposed to LPS in the presence or absence of hypertonicity or SB203580 (p38 inhibitor). CD11b and CD14 were studied by immunofluorescence and p38 phosphorylation by immunoblotting.
RESULTS: Hypertonicity had no effect on CD11b or CD14, caused a weak p38 phosphorylation, and completely prevented the LPS-induced p38 phosphorylation and CD11b up-regulation. p38 inhibition also abrogated CD11b up-regulation by LPS.
CONCLUSION: MAPKp38 is important in CD11b regulation by LPS. The inhibitory effect of hypertonicity on the LPS-mediated effect may contribute to its protective anti-inflammatory effect observed in vivo. Transient hypertonicity might minimize organ injury in diseases characterized by neutrophil-mediated damage such as ARDS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338395     DOI: 10.1097/00005373-199905000-00006

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

Review 1.  Normalizing physiological variables in acute illness: five reasons for caution.

Authors:  Brian P Kavanagh; L Joanne Meyer
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

2.  The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial.

Authors:  Sandro B Rizoli; Shawn G Rhind; Pang N Shek; Kenji Inaba; Dennis Filips; Homer Tien; Fred Brenneman; Ori Rotstein
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 3.  Intravenous Fluid Therapy in Traumatic Brain Injury and Decompressive Craniectomy.

Authors:  Hernando Raphael Alvis-Miranda; Sandra Milena Castellar-Leones; Luis Rafael Moscote-Salazar
Journal:  Bull Emerg Trauma       Date:  2014-01

4.  Hypertonic saline resuscitation improves intestinal microcirculation in a rat model of hemorrhagic shock.

Authors:  El Rasheid Zakaria; Nina L Tsakadze; R Neal Garrison
Journal:  Surgery       Date:  2006-09-06       Impact factor: 3.982

5.  Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils.

Authors:  M Forsberg; R Löfgren; L Zheng; O Stendahl
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

Review 6.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

7.  Inhibition of acid-induced lung injury by hyperosmolar sucrose in rats.

Authors:  Zeenat Safdar; Maimiti Yiming; Gabriele Grunig; Jahar Bhattacharya
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

8.  Effects of intestinal lymph on expression of neutrophil adhesion factors and lung injury after trauma-induced shock.

Authors:  Zuo-Bing Chen; Shu-Sen Zheng; Gao Yuan; Chen-Yan Ding; Yun Zhang; Xue-Hong Zhao; Lin-Mei Ni
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation.

Authors:  Conor J Shields; Adrian W O'Sullivan; Jiang H Wang; Desmond C Winter; William O Kirwan; H Paul Redmond
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

10.  Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock.

Authors:  Eileen M Bulger; Joseph Cuschieri; Keir Warner; Ronald V Maier
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.